Facible BioDiagnostics, Inc.
New Filing
CIK: 0001910594·Biotechnology·DELAWARE·Filed: May 6, 2022
Total Offering
$1,841,945
Amount Sold
$861,925
Investors
3
First Sale
May 3, 2022
Offering Details
- Type
- Equity, Other: Class A Common Stock
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2019
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Steven Burden | Related Person |
| Matthew Hawkins | Related Person |
| Casi Wyatt | Related Person |
| Eric Hayden | Related Person |
| Brent Fawson | Related Person |
| Clementine Gibard Bohachek | Related Person |
| Micah Kormylo | Related Person |
Company
SEC Filing
0001888078-22-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free